论文信息 - Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib - 字舞流文

Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib

W. T. van der Graaf | E. Fleuren | Y. Versleijen-Jonkers | W. V. D. van der Graaf | M. Hillebrandt-Roeffen | A. V. van Erp | Laurens van Houdt | Anke E M van Erp | M. H. Hillebrandt-Roeffen